References
- Munro AJ. Multidisciplinary team meetings in cancer care: an idea whose time has gone? Clin Oncol. 2015;27:728–731. doi:10.1016/j.clon.2015.08.008
- Calman K, Hine D. A policy framework for commissioning cancer services; a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales; 1995.
- Ruhstaller T, Roe H, Thürlimann B, et al. The MDT: an indispensable aid to communication between different specialties. Eur J Cancer. 2006;42(15):2459–2462. doi:10.1016/j.ejca.2006.03.034
- Taylor C, et al. Multidisciplinary team working in cancer; what is the evidence? BMJ. 2010;340:c951.
- Cancer Waiting Times Annual Report 2015/16 p4 section 1.2 table 1.1 Published to the NHS England website, in electronic PDF format only. Available from: http://www.england.nhs.uk/statistics/statistical-work-areas/. Accessed December 30, 2020.
- Cancer Waiting Times Annual Report 2016/17 p4 section 1.2 table 1.1 Published to the NHS England website, in electronic PDF format only. Available from: http://www.england.nhs.uk/statistics/statistical-work-areas/. Accessed December 30, 2020.
- Cancer Waiting Times Annual Report 2017/18 p4 section 1.2 table 1.1 Published to the NHS England website, in electronic PDF format only. Available from: http://www.england.nhs.uk/statistics/statistical-work-areas/. Accessed December 30, 2020.
- Lacobucci G. Patients left waiting for cancer treatment as targets missed, BMA analysis shows. BMJ. 2019;365:I2039. doi:10.1136/bmj.l2039
- De Iso PB, Coward JI, Letsa I, et al. A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology. Br J Cancer. 2013;109(9):2295–2300. doi:10.1038/bjc.2013.586
- Fleissig A, Jenkins V, Catt S, et al. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol. 2006;7(11):935–943. doi:10.1016/S1470-2045(06)70940-8
- Cancer Research UK ‘meeting patients’ needs: improving the effectiveness of multidisciplinary team meetings’ January 2017. Published to the Cancer Research UK website, in electronic PDF format only. Available from: https://www.cancerresearchuk.org/about-us/we-develop-policy/our-policy-on-cancer-services/improving-the-effectiveness-of-mdts-in-cancer-services. Accessed December 30, 2020.
- Chinai N, Bintcliffe F, Armstrong EM, et al. Does every patient need to be discussed at a multidisciplinary team meeting? Clin Radiol. 2013;68(8):780–784. doi:10.1016/j.crad.2013.02.011
- Jalil R, Ahmed M, Green JSA, et al. Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: an interview study of the provider perspective. Int J Surg. 2013;11(5):389–394. doi:10.1016/j.ijsu.2013.02.026
- Transforming multidisciplinary team meetings. Martin Gore; 2017
- “Achieving world-class cancer outcomes: a strategy for England” section 5.5.1. The Independent Cancer Taskforce; July 2015
- Dangoor A, Seddon B, Gerrand C, et al. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016;6:20. doi:10.1186/s13569-016-0060-4
- Gerrand C, Athanasou N, Brennan B, et al. UK guidelines for the management of bone sarcomas. Clin Sarcoma Res. 2016;6:7. doi:10.1186/s13569-016-0047-1
- Grimer R, et al. UK guidelines for the management of bone sarcomas. Sarcoma. 2010;2010:317462.
- West Midlands Cancer Intelligence Unit. Bone and soft tissue sarcomas UK incidence and survival: 1996 to 2010; 2013.
- National Cancer Registration and Analysis Service. Soft tissue sarcomas: incidence and survival rates in England; 2011.
- Boo SL, Botchu R, McLoughlin E, et al. Commentary: sarcoma multidisciplinary team meeting, past, present and future. Clin Radiol. 2020;75:316–318. doi:10.1016/j.crad.2019.12.015
- Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer. 2015;112(1):S1–5. doi:10.1038/bjc.2015.23
- Pencavel TD, Strauss DC, Thomas GP, et al. Does the two-week rule pathway improve the diagnosis of soft tissue sarcoma? A retrospective review of referral patterns and outcomes over five years in a regional sarcoma centre. Ann R Coll Surg Engl. 2010;92(5):417–4211. doi:10.1308/003588410X12664192075972
- Chang AE, et al. Multidisciplinary cancer clinics: their time has come. J Surg Oncol. 1998;69:203–205. doi:10.1002/(SICI)1096-9098(199812)69:4<203::AID-JSO2>3.0.CO;2-Z
- Smith GM, Johnson GD, Grimer RJ, et al. Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis. Ann R Coll Surg Engl. 2011;93(7):542–547. doi:10.1308/147870811X13137608455055
- Bauer HC, Trovik CS, Alvegård TA, et al. Monitoring referral and treatment in soft tissue sarcoma: study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand. 2001;72:150–159. doi:10.1080/000164701317323408
- Di Girolamo C, Walters S, Gildea C, et al. Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009–2013. PLoS One. 2018;13(8):e0201288. doi:10.1371/journal.pone.0201288
- Brocken P, Prins JB, Dekhuijzen PNR, et al. The faster the better? A systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways. Psychooncology. 2012;21(1):1–10. doi:10.1002/pon.1929
- Saegrov S, Halding A-G. What is it like living with a diagnosis of cancer? Eur J Cancer Care (Engl). 2004;13(2):145–153. doi:10.1111/j.1365-2354.2004.00442.x
- Scott CEH, MacDonald DJ, Howie CR, et al. ‘Worse than death’ waiting for a joint arthroplasty. Bone Joint J. 2019;101-B(8):941–950. doi:10.1302/0301-620X.101B8.BJJ-2019-0116.R1
- Chaudhry SR, Tsetse C, Chennan SE, et al. Early recognition and diagnosis of Ewing Sarcoma of the cervical spine. Radiol Case Rep. 2019;14(2):160–163. doi:10.1016/j.radcr.2018.09.017
- Loud J, Murphy J. Cancer screening and early detection in the 21 st century. Semin Oncol Nurs. 2018;33(2):121–128. doi:10.1016/j.soncn.2017.02.002